EcoDrugPlus

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSSTUG00000030728
Gene Symbol: LOC115190837
3 Cross references
198 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSSTUG00000038998
Gene Symbol: LOC115190784
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSSTUG00000008337
Gene Symbol: LOC115157316
3 Cross references
190 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSSTUG00000003041
Gene Symbol: LOC115194394
3 Cross references
192 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSSTUG00000024317
Gene Symbol: LOC115198396
3 Cross references
192 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSSTUG00000010419
Gene Symbol: LOC115169490
3 Cross references
190 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSSTUG00000033601
Gene Symbol: LOC115206458
2 Cross references
161 Possible Orthologues:

Matrix Metalloproteinase-9-Like

Ensembl ID : ENSSTUG00000038105
Gene Symbol: LOC115168666
3 Cross references
209 Possible Orthologues:

Matrix Metalloproteinase-9-Like

Ensembl ID : ENSSTUG00000015832
Gene Symbol: LOC115165351
3 Cross references
209 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSSTUG00000008045
Gene Symbol: MTOR
3 Cross references
217 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSSTUG00000014295
Gene Symbol: MC1R
1 Cross references
154 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSSTUG00000020496
Gene Symbol: MC1R
1 Cross references
155 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).